Circulating SOD2 Is a Candidate Response Biomarker for Neoadjuvant Therapy in Breast Cancer

SIMPLE SUMMARY: The development of specific biomarkers to monitor response to the several available cancer drugs is a major challenge for modern clinical oncology. A reasonable solution for this problem could be to use circulating biomarkers linked to the tumor cell death induced by therapeutic trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Juliachs, Mercè, Pujals, Mireia, Bellio, Chiara, Meo-Evoli, Nathalie, Duran, Juan M., Zamora, Esther, Parés, Mireia, Suñol, Anna, Méndez, Olga, Sánchez-Pla, Alex, Canals, Francesc, Saura, Cristina, Villanueva, Josep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405919/
https://www.ncbi.nlm.nih.gov/pubmed/36010852
http://dx.doi.org/10.3390/cancers14163858

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405919/
https://www.ncbi.nlm.nih.gov/pubmed/36010852
http://dx.doi.org/10.3390/cancers14163858

Ejemplares similares